Literature DB >> 9733288

Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome.

R Vanhala1, L Korhonen, M Mikelsaar, D Lindholm, R Riikonen.   

Abstract

Rett syndrome is now considered to be a neurodevelopmental disease. Its cause is unknown, but it has been suggested that neuronal growth factors and neurotransmitters play important roles. We measured levels of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in cerebrospinal fluid, and nerve growth factor and brain-derived neurotrophic factor in serum in child and adolescent patients with Rett syndrome. Levels of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in cerebrospinal fluid were below the limit of sensitivity of the methods used. Serum levels of nerve growth factor and brain-derived neurotrophic factor did not differ from control values. In Rett syndrome, the normal serum levels of nerve growth factor together and previously reported low levels of the factor in cerebrospinal fluid indicate that the latter may reflect low levels of nerve growth factor in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733288     DOI: 10.1177/088307389801300903

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

Review 1.  Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome.

Authors:  Michelle D Amaral; Christopher A Chapleau; Lucas Pozzo-Miller
Journal:  Pharmacol Ther       Date:  2006-11-21       Impact factor: 12.310

2.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Authors:  Jennifer L Larimore; Christopher A Chapleau; Shinichi Kudo; Anne Theibert; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-01-03       Impact factor: 5.996

3.  Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism.

Authors:  Christopher A Chapleau; Jennifer L Larimore; Anne Theibert; Lucas Pozzo-Miller
Journal:  J Neurodev Disord       Date:  2009-09       Impact factor: 4.025

Review 4.  BDNF deregulation in Rett syndrome.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

5.  PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.

Authors:  Navasona Krishnan; Keerthi Krishnan; Christopher R Connors; Meng S Choy; Rebecca Page; Wolfgang Peti; Linda Van Aelst; Stephen D Shea; Nicholas K Tonks
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

6.  Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome.

Authors:  F Guideri; M Acampa; G Calamandrei; L Aloe; M Zappella; Y Hayek
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

Review 7.  Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders.

Authors:  Marianna Stamou; Karin M Streifel; Paula E Goines; Pamela J Lein
Journal:  Neurotoxicol Teratol       Date:  2012-12-23       Impact factor: 3.763

8.  Brain derived neurotrophic factor and serotonin transporter binding as markers of clinical response to fluoxetine therapy in children with autism.

Authors:  Ismo Makkonen; Raili Riikonen; Jyrki T Kuikka; Hannu Kokki; Joseph P Bressler; Cathleen Marshall; Walter E Kaufmann
Journal:  J Pediatr Neurol       Date:  2011-03

Review 9.  Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.

Authors:  Shervin Pejhan; Mojgan Rastegar
Journal:  Biomolecules       Date:  2021-01-08

Review 10.  The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models.

Authors:  Lisa Mapelli; Teresa Soda; Egidio D'Angelo; Francesca Prestori
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.